Roelof van Ewijk
Overview
Explore the profile of Roelof van Ewijk including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
22
Citations
82
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Ewijk R, Dandis R, Rodewijk J, de Keizer B, Ter Horst S, van de Sande M, et al.
Eur Radiol
. 2025 Jan;
PMID: 39853333
Objective: To investigate the prognostic value of baseline European Association of Nuclear Medicine Research Ltd. (EARL) standardized [F]fluorodeoxyglucose positron emission tomography-computed tomography ([F]FDG PET-CT) quantitative values for survival and to...
2.
Terwisscha van Scheltinga S, Schoot R, Routh J, Seitz G, Kao S, de Keizer B, et al.
Pediatr Blood Cancer
. 2025 Jan;
72(4):e31538.
PMID: 39844722
Accurate staging of nodal involvement in pediatric sarcoma patients is important to determine correct systemic and local therapy, with the goal to reduce subsequent recurrences. However, differences in lymph node...
3.
Bryan G, Guolla L, Villanueva G, Cohen-Gogo S, Casanovas A, Medina R, et al.
Pediatr Blood Cancer
. 2024 Nov;
72(1):e31419.
PMID: 39502016
Introduction: The COVID-19 pandemic onset had a global debilitating impact on individuals and on burgeoning careers. In 2021, the Children's Oncology Group Young Investigators Committee, Young SIOP (International Society of...
4.
Chisholm J, Mandeville H, Adams M, Minard-Collin V, Rogers T, Kelsey A, et al.
Cancers (Basel)
. 2024 Oct;
16(19).
PMID: 39410054
The authors wish to make corrections to the authorship and title of [...].
5.
Green D, Ewijk R, Tirtei E, Andreou D, Baecklund F, Baumhoer D, et al.
Clin Cancer Res
. 2024 Jun;
30(16):3395-3406.
PMID: 38869831
Osteosarcoma and Ewing sarcoma are bone tumors mostly diagnosed in children, adolescents, and young adults. Despite multimodal therapy, morbidity is high and survival rates remain low, especially in the metastatic...
6.
Chisholm J, Mandeville H, Adams M, Minard-Collin V, Rogers T, Kelsey A, et al.
Cancers (Basel)
. 2024 Mar;
16(5).
PMID: 38473359
The Frontline and Relapsed Rhabdomyosarcoma (FaR-RMS) clinical trial is an overarching, multinational study for children and adults with rhabdomyosarcoma (RMS). The trial, developed by the European Soft Tissue Sarcoma Study...
7.
Schoot R, Ewijk R, von Witzleben A, Kao S, Hans Merks J, Morosi C, et al.
Eur J Radiol
. 2023 Sep;
168:111108.
PMID: 37774530
No abstract available.
8.
Ewijk R, Cleirec M, Herold N, Le Deley M, van Eijkelenburg N, Boudou-Rouquette P, et al.
Cancer Treat Rev
. 2023 Sep;
120:102625.
PMID: 37738712
Background/objective: To analyze changes in recurrent/refractory osteosarcoma phase II trials over time to inform future trials in this population with poor prognosis. Methods: A systematic review of trials registered on...
9.
Ewijk R, Chatziantoniou C, Adams M, Bertolini P, Bisogno G, Bouhamama A, et al.
Pediatr Radiol
. 2023 Sep;
53(12):2539-2551.
PMID: 37682330
Objective: To investigate the feasibility of diffusion-weighted magnetic resonance imaging (DW-MRI) as a predictive imaging marker after neoadjuvant chemotherapy in patients with rhabdomyosarcoma. Material And Methods: We performed a multicenter...
10.
Gelineau N, van Barneveld A, Samim A, Van Zogchel L, Lak N, Tas M, et al.
Front Oncol
. 2023 Sep;
13:1209150.
PMID: 37664065
Background And Aims: Solid tumors account for about 30% of all pediatric cancers. The diagnosis is typically based on histological and molecular analysis of a primary tumor biopsy. Liquid biopsies...